Evidence map›Paper›PMID 37305999›Full record

ArticleJournal of cell science2023

Cik1 and Vik1 accessory proteins confer distinct functions to the kinesin-14 Kar3.

Zane J Bergman, Jonathan J Wong, David G Drubin, Georjana Barnes

Abstract read
In one paragraph

Article in Journal of cell science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zane J BergmanDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.
Jonathan J WongDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.
David G DrubinDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.ORCID 0000-0003-3002-6271
Georjana BarnesDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.ORCID 0000-0003-2083-358X

Funding

SACCHAROMYCES CEREVISIAE MICROTUBULE CYTOSKELETONR01GM047842 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARNES, GEORJANA · 1993 to 2022
$7.5M
Saccharomyces cerevisiae microtubule and kinetochore dynamicsR35GM149237 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI GEORJANA BARNES · 2023 to 2026
$1.8M
NIGMS NIH HHS R35 GM149237NIH HHS R01 GM 47842
6 · The paper itself

Abstract

The budding yeast Saccharomyces cerevisiae has a closed mitosis in which the mitotic spindle and the cytoplasmic microtubules (MTs), both of which generate forces to faithfully segregate chromosomes, remain separated by the nuclear envelope throughout the cell cycle. Kar3, the yeast kinesin-14, has distinct functions on MTs in each compartment. Here, we show that two proteins, Cik1 and Vik1, which form heterodimers with Kar3, regulate its localization and function within the cell, and along MTs in a cell cycle-dependent manner. Using a yeast MT dynamics reconstitution assay in lysates from cell cycle-synchronized cells, we found that Kar3-Vik1 induces MT catastrophes in S phase and metaphase, and limits MT polymerization in G1 and anaphase. In contrast, Kar3-Cik1 promotes catastrophes and pauses in G1, while increasing catastrophes in metaphase and anaphase. Adapting this assay to track MT motor protein motility, we observed that Cik1 is necessary for Kar3 to track MT plus-ends in S phase and metaphase but, surprisingly, not during anaphase. These experiments demonstrate how the binding partners of Kar3 modulate its diverse functions both spatially and temporally.

Indexed as

KinesinsSaccharomyces cerevisiaeAnaphaseCell CycleMetaphaseKinesinsCell cycleKar3Kinesin-14MicrotubulesReconstitution

Identifiers

PMID37305999
PMCPMC10281266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.